ALFA Finder| Management target | Revenue 10.0% FY27 |
|---|
| Revenue growth | 23% YoY consolidated growth in Q1FY27. |
|---|---|
| Margins | EBITDA margin expanded 40 bps YoY to 20.7%. |
| Demand visibility | Resilient domestic activity supported by private consumption. |
| Management confidence | High; citing multi-quarter high volume growth in India. |
Growth
Consolidated revenue rose 23% YoY to ₹3,957 Cr; EBITDA grew 25% to ₹819 Cr with a 20.7% margin. Domestic volumes up 11%.
Outlook
Guidance of double-digit revenue growth to exceed ₹15,000 Cr in FY27; long-term vision of ₹20,000 Cr+ topline by 2030.
Risks
Global supply chain disruptions and inflation drive upticks in input costs; monsoon progression remains a key monitorable.
Last quarter's promises, checked
Delivered
- Guided double-digit revenue growth → delivered 23% (= BEAT)
- Guided high single-digit India volume growth → delivered 11% (= BEAT)
- Guided high-teen EBITDA growth → delivered 25% (= BEAT)
Partly delivered
- Guided 150-200 bps margin expansion → delivered 40 bps (= PARTIAL)
Investor Presentation filed with BSE, NSE: MARICO. Summary written with AI assistance from the document.
Marico Ltd: key numbers
- Share price
- ₹907.45
- Market cap
- ₹1,17,987 Cr
- Revenue (annual)
- ₹13,611 Cr
- Net profit (annual)
- ₹1,762 Cr
- P/E (TTM)
- 58.5×Sector 41.3×
- Promoter holding
- 58.83%-0.08% QoQ
- FII holding
- 22.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marico Ltd
All →Marico Acquisition Worth ₹35 Cr
Marico will acquire 51% of Bonorizon Consumer Ventures via primary subscription for up to Rs 35 crore in cash. Completion is expected within 90 days of signing definitive agreements.
- Value
- ₹35.00 Cr
- Execution
- Within 90 days from signing of definitive agreements
Marico Acquisition Worth ₹113.7 Cr
Marico bought a further 20% stake in Cosmix Wellness for Rs. 113.65 Crore cash. Its holding rises from 60% to 80%.
- Value
- ₹113.7 Cr
Marico Annual General Meeting
Marico seeks postal ballot approval to appoint Rohit Jawa as Independent Director from 1 January 2027 for five years. Remote e-voting ends 7 December 2026.
Marico Earnings Call Transcript: Key Takeaways
Strong Q2: revenue +13%, EBITA +27%, PAT +31%, EBITA margin 18.2%, helped by softer copra and mix. FY27 EBITDA guidance raised to mid-20s growth, while A&P spend rose 44%.
- Call
- Guides 13% growth
Marico Management Change
Marico's board appointed Mr. Rohit Jawa as Additional Independent Director for a five-year term. Shareholder approval will be sought via postal ballot.
Marico Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹3,897 Cr (+13%), EBITDA ₹709 Cr (+27%), PAT ₹550 Cr (+31%); volume-led growth with Foods and Premium Personal Care scaling.